Eli Lilly and Company (NYSE: LLY) has released detailed results from the SURMOUNT-OSA phase 3 clinical trials, which evaluated tirzepatide injections (10 mg or 15 mg) for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity, with and without…
Sanofi and Biovac, based in Cape Town, South Africa, have announced a significant partnership aimed at local manufacturing of inactivated polio vaccines (IPV) across Africa. This collaboration marks a milestone as Biovac becomes the first African producer of IPV on…
Takeda Releases Phase 3 Topline Results for Soticlestat (TAK-935) in Dravet Syndrome and Lennox-Gastaut Syndrome OSAKA, Japan & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Takeda (TSE:4502/NYSE The SKYLINE trial (TAK-935-3001) was a multicenter, randomized, double-blind Phase 3 study examining soticlestat (TAK-935) alongside standard care…
UMC Utrecht has enrolled its first patient for a new study to identify biomarkers of Amyotrophic Lateral Sclerosis (ALS). The observational investigator-initiated study is led by Professor Dr. Leonard van den Berg and supported by VectorY Therapeutics. VectorY Therapeutics is…
Celltrion today presented positive Phase III data for CT-P47, a biosimilar referencing RoActemra® in patients with moderate-to-severe rheumatoid arthritis (RA), at the Annual European Congress of Rheumatology (EULAR) 2024. The trial demonstrated that CT-P47 has equivalent efficacy and comparable safety…
Kirin Holdings Company, Limited (Kirin Holdings) (TOKYO: 2503) has announced its intention to acquire additional shares of common stock of FANCL Corporation (FANCL) (TOKYO: 4921) through a tender offer and share warrants, with the goal of making FANCL a wholly-owned…
The World Health Organization has released a new guideline outlining effective strategies to foster food environments that support healthy dietary choices. Emphasizing fiscal policies as a pivotal tool, the guideline recommends measures to discourage consumption of foods linked to unhealthy…
Zimbabwe has reached maturity level 3 (ML 3) in the WHO’s classification of regulatory authorities for medicines, marking a significant achievement in healthcare infrastructure. This classification, assessed using WHO’s Global Benchmarking Tool with over 260 indicators, signifies the establishment of…
Today, Takeda has announced a significant step forward in its oncology portfolio with the signing of an option agreement with Ascentage Pharma. This agreement paves the way for Takeda to potentially enter into an exclusive global license for olverembatinib, a…
eClinical Solutions, a global leader in digital clinical software and services, has announced its participation in several upcoming industry events aimed at advancing biopharma efficiency through its elluminate® platform and biometrics services. These engagements come at a pivotal moment as…
CMI Media Group, a global healthcare media strategy agency and part of WPP (NYSE: WPP), has announced a pioneering partnership with KERV Interactive, a leader in AI-powered video analysis, performance, and monetization. This collaboration introduces innovative ‘Video Attention’ metrics tailored…
AstraZeneca’s supplemental New Drug Application (sNDA) for Tagrisso has been accepted and granted Priority Review in the US for treating adult patients with unresectable, Stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after chemoradiotherapy (CRT). If…